Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Alzinova announced today the successful outcome of the TO4 warrant exercise, completing the bridging financing package initiated with the rights issue earlier this year.</li><li>While a strategic partnership is still a necessary long-term funding solution for the planned phase II study of ALZ-101, we view the 94.2% exercise rate as an encouraging outcome that strengthens the company’s financial position, extends its operational runway, and provides additional flexibility in ongoing partnership discussions.</li></ul>

Alzinova announced today the successful outcome of the TO4 warrant exercise, completing the bridging financing package initiated with the rights issue earlier this year.While a strategic partnership is still a necessary long-term funding solution for the planned phase II study of ALZ-101, we view the 94.2% exercise rate as an encouraging outcome that strengthens the company’s financial position, extends its operational runway, and provides additional flexibility in ongoing partnership discussions.

Alzinova: High subscription rate in TO4 warrants